Celltrion Pharm

068760.KQ

36.52 USD

-0.16

-0.44%

Overview

Last close

36.52 usd

Market cap

1.51B usd

52 week high

93.83 usd

52 week low

33.02 usd

Target price

94.91 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.2893

Price/Book Value

5.8395

Enterprise Value

1.68B usd

EV/Revenue

5.4984

EV/EBITDA

47.4137

Key financials

Revenue TTM

191.72M usd

Gross Profit TTM

50.90M usd

EBITDA TTM

29.86M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

494.73M usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.